|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.98 CHF | +0.53% |
|
-0.84% | +19.48% |
| 12-11 | Tristan Imbert Appointed to Euroapi Board of Directors |  |
| 12-10 | Teva Pharmaceuticals Requests Removal of Some Patents From FDA Listing After FTC Warning | DJ |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Innovative Medicines | 40.82B | 43.97B | 43.37B | 46.66B | 51.72B | |||||
Total Assets | 83.11B | 79.22B | 75.51B | 99.94B | 102B | |||||
Interest Expense | - | - | - | -855M | -1.01B | |||||
Income Tax Expense | - | - | - | 551M | 1.7B | |||||
CAPEX | -2.42B | -2.7B | -2.63B | -1.06B | -1.37B | |||||
EBT | - | - | - | 9.12B | 13.64B | |||||
Gross Profit | 29.9B | 32.22B | 31.8B | 34.19B | 38.9B | |||||
D&A | 4.26B | 4.76B | 4.82B | 5.14B | 4.6B | |||||
Operating Income | 9.17B | 10.69B | 8.79B | 9.77B | 14.54B | |||||
Net Income | - | - | - | 14.85B | 11.94B | |||||
Sandoz | 9.89B | 9.87B | 9.48B | - | - | |||||
Total Assets | 16.82B | 16.19B | 16.08B | - | - | |||||
CAPEX | -401M | -477M | -455M | - | - | |||||
Gross Profit | 4.64B | 4.72B | 4.5B | - | - | |||||
D&A | 693M | 487M | 459M | - | - | |||||
Operating Income | 1.04B | 1.6B | 1.45B | - | - | |||||
Optical Healthcare | ||||||||||
Alcon | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Corporate (Including Eliminations) | -813M | -964M | -1.02B | - | - | |||||
Total Assets | 32.12B | 36.38B | 25.86B | - | - | |||||
CAPEX | -210M | -306M | -224M | - | - | |||||
Gross Profit | 245M | 67M | 37M | - | - | |||||
D&A | 152M | 180M | 169M | - | - | |||||
Operating Income | -63M | -599M | -1.04B | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 16.48B | 16.82B | 17.65B | 17.96B | 21.15B | |||||
Total Assets | 39.89B | 37.05B | 35.35B | 34.06B | 35B | |||||
Other | 19.04B | 20.81B | 20.05B | 15.87B | 18.51B | |||||
Total Assets | 7.84B | 7.35B | 8.24B | 4.27B | 4.6B | |||||
China | 2.57B | 3.05B | 3.13B | 3.27B | 3.89B | |||||
Total Assets | 714M | 703M | 599M | 547M | 530M | |||||
Germany | 4.52B | 4.87B | 4.28B | 3.37B | 3.66B | |||||
Total Assets | 2.61B | 2.38B | 2.23B | 88M | 1.55B | |||||
France | 2.44B | 2.52B | 2.26B | 1.75B | 1.79B | |||||
Total Assets | 4.12B | 3.62B | 3.19B | 3.08B | 2.64B | |||||
Switzerland | 800M | 873M | 970M | 1.31B | 1.32B | |||||
Total Assets | 34.9B | 25.77B | 23.71B | 19.4B | 18.76B | |||||
United Kingdom | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Japan | 2.8B | 2.68B | 2.2B | 1.92B | - | |||||
Total Assets | 313M | 217M | 165M | 120M | - |
- Stock Market
- Equities
- NOVN Stock
- Financials Novartis AG
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition